Journal article
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure
Abstract
BACKGROUND: Chronic heart failure remains a major cause of mortality and morbidity. The role of antithrombotic therapy in patients with chronic heart failure has long been debated. The objective of this study was to determine the optimal antithrombotic agent for heart failure patients with reduced ejection fractions who are in sinus rhythm.
METHODS AND RESULTS: This prospective, randomized clinical trial of open-label warfarin (target …
Authors
Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JGF; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA
Journal
Circulation, Vol. 119, No. 12, pp. 1616–1624
Publisher
Wolters Kluwer
Publication Date
March 31, 2009
DOI
10.1161/circulationaha.108.801753
ISSN
0009-7322